Form Type: 4

SEC EDGAR Link
Acccession Number:0000914190-19-000370
Date:2019-09-09
Issuer: BIO-TECHNE CORP (TECH)
Original Submission Date:

Reporting Person:

KUMMETH CHARLES R.
614 MCKINLEY PLACE NE
MINNEAPOLIS, MN 55413

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2019-09-09 P 100 a $185.00 100 indirect
COMMON STOCK 2019-09-09 P 100 a $185.00 100 indirect
COMMON STOCK 0 $0.00 135,856 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTIONS (RIGHT TO BUY) 67.46 deemed execution date 0 ( ) 2020-04-01 common stock 57,590 $67.46 57,590 direct
STOCK OPTIONS (RIGHT TO BUY) 86.25 deemed execution date 0 ( ) 2021-04-01 common stock 46,316 $86.25 46,316 direct
STOCK OPTIONS (RIGHT TO BUY) 94.35 deemed execution date 0 ( ) 2021-08-12 common stock 66,849 $94.35 66,849 direct
STOCK OPTIONS (RIGHT TO BUY) 108.49 deemed execution date 0 ( ) 2022-08-07 common stock 95,346 $108.49 95,346 direct
STOCK OPTIONS (RIGHT TO BUY) 108.49 deemed execution date 0 ( ) 2022-08-07 common stock 79,517 $108.49 79,517 direct
STOCK OPTIONS (RIGHT TO BUY) 106.59 deemed execution date 0 ( ) 2023-08-18 common stock 154,169 $106.59 154,169 direct
STOCK OPTIONS (RIGHT TO BUY) 106.59 deemed execution date 0 ( ) 2023-08-18 common stock 102,779 $106.59 102,779 direct
RESTRICTED STOCK UNITS 0.0 deemed execution date 0 ( ) common stock 21,291 $0.00 21,291 direct
STOCK OPTIONS (RIGHT TO BUY) 125.05 deemed execution date 0 ( ) 2024-08-09 common stock 117,342 $125.05 117,342 direct
STOCK OPTIONS (RIGHT TO BUY) 125.05 deemed execution date 0 ( ) 2024-08-09 common stock 78,228 $125.05 78,228 direct
RESTRICTED STOCK UNITS 0.0 deemed execution date 0 ( ) common stock 16,918 $0.00 16,918 direct
STOCK OPTIONS (RIGHT TO BUY) 177.32 deemed execution date 0 ( ) 2025-08-08 common stock 90,334 $177.32 90,334 direct
STOCK OPTIONS (RIGHT TO BUY) 177.32 deemed execution date 0 ( ) 2025-08-08 common stock 60,222 $177.32 60,222 direct
RESTRICTED STOCK UNITS 0.0 deemed execution date 0 ( ) common stock 16,937 $0.00 16,937 direct
STOCK OPTIONS (RIGHT TO BUY) 190.41 deemed execution date 0 ( ) 2026-08-07 common stock 85,725 $190.41 85,725 direct
STOCK OPTIONS (RIGHT TO BUY) 190.41 deemed execution date 0 ( ) 2026-08-07 common stock 57,150 $190.41 57,150 direct
Footnotes
IDfootnote
f1 includes (i) 4,732 shares of restricted stock for which the risk of forfeiture will lapse on august 9, 2020; (ii) 7,519 shares of restricted stock for which the risk of forfeiture will lapse as to 3,760 shares on august 8, 2020 and as to 3,759 shares on august 8, 2021; and (iii) 11,291 shares of restricted stock for which the risk of forfeiture will lapse with respect to 3,764 shares on each of august 7, 2020 and august 7, 2021 and as to 3,763 shares on august 7, 2022.
f2 fully exercisable.
f3 options to purchase 25,695 shares vest on each of 8/18/2017, 8/18/2018 and 8/18/2019 and options to purchase 25,695 shares vest on 8/18/2020.
f4 each restricted stock unit represents a contingent right to receive one share of bio-techne common stock.
f5 vests in full or in part on 8/9/2020 if certain performance goals are achieved (or such later date as performance is certified by the administrator).
f6 options to purchase 19,557 shares vest on each of 8/9/2018, 8/9/2019, 8/9/2020 and 8/9/2021.
f7 vests in full or in part on 8/8/2021 if certain performance goals are achieved (or such later date as performance is certified by the administrator).
f8 options to purchase 15,056 shares vest on each of 8/8/2019 and 8/8/2020 and options to purchase 15,055 shares vest on each of 8/8/2021 and 8/8/2022.
f9 vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the administrator).
f10 options to purchase 14,288 shares vest on each of 8/7/2020 and 8/7/2021 and options to purchase 14,287 shares vest on each of 8/7/2022 and 8/7/2023.

Elevate your investments